HTA Quarterly | Summer 2017
By Xcenda |
We take a look at patient input into HTA decisions in 4 countries, examining new therapies for Duchenne Muscular Dystrophy, and understanding the Colombian universal healthcare model.
Hearing the Patient Voice Loud and Clear
A Look at 4 Countries and Their Use of Input From Patients and Patient Organizations
Therapeutic Spotlight: Duchenne Muscular Dystrophy: New and Revitalized Drugs Bring Hope to Patients
Colombia: A Unique Universal Healthcare Model in Latin America